The project is aimed to identify the global metabolite biomarkers in COVID-19 infected patients. It helps in search of potential biomarker signature for COVID infection and recognition of novel targets for therapy. Metabolites are small molecules that get formed during the cellular processes, which can act as unique biomarkers for a disease. This will help scientists in search for molecular signs of the infection. These molecules can then be targeted with novel therapies.